Holen Sie sich die Stockscreener-App
1.26
16.67%
0.18
Handel nachbörslich:
1.21
-0.05
-3.97%
Schlusskurs vom Vortag:
$1.08
Offen:
$1.09
24-Stunden-Volumen:
5.46M
Relative Volume:
4.52
Marktkapitalisierung:
$113.81M
Einnahmen:
$70.14M
Nettoeinkommen (Verlust:
$-76.24M
KGV:
-1.1351
EPS:
-1.11
Netto-Cashflow:
$-57.06M
1W Leistung:
+17.76%
1M Leistung:
-0.79%
6M Leistung:
-47.93%
1J Leistung:
-53.85%
1-Tages-Spanne:
$1.09
$1.2899
1-Wochen-Bereich:
$0.9583
$1.2899
52-Wochen-Spanne:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
1.26 | 97.55M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
Clean the SkyClean Pharmaceutical Manufacturings - Trend Hunter
Codexis signs deal to produce siRNA for pharma partner - Investing.com
Why Did CDXS Stock Jump 7% Today? - Stocktwits
Codexis to Produce 50 Grams of siRNA Using ECO Synthesis Manufacturing Platform - geneonline.com
Codexis Agrees to Manufacture 50 Grams of siRNA Using its Proprietary Manufacturing Platform - Contract Pharma
Codexis (CDXS) Partners for siRNA Manufacturing in Cardiovascula - GuruFocus
Biotech Codexis tapped to scale RNA ingredient for heart drug research - Stock Titan
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform - Yahoo Finance
Codexis at TD Cowen Conference: Strategic Shift to RNA Medicines - Investing.com
CDXS SEC FilingsCodexis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
CDXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CDXS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
[Form 4] CODEXIS, INC. Insider Trading Activity - Stock Titan
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 - GlobeNewswire
5,280-share RSU vesting sale at CDXS (NASDAQ: CDXS) - Stock Titan
Codexis Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Codexis (CDXS) Projected to Post Earnings on Thursday - MarketBeat
Is Codexis (NASDAQ:CDXS) Weighed On By Its Debt Load? - 富途牛牛
Codexis to Participate in TD Cowen 46th Annual Health Care Conference - The Manila Times
Enzyme solutions provider Codexis plans TD Cowen fireside chat - Stock Titan
What makes Codexis Inc. stock attractive to growth fundsMarket Activity Report & Weekly High Return Forecasts - mfd.ru
What’s next for Codexis Inc. stock2025 Historical Comparison & Risk Managed Investment Entry Signals - mfd.ru
Positive Sentiment Still Eludes Codexis, Inc. (NASDAQ:CDXS) Following 29% Share Price Slump - simplywall.st
Macro Review: Does Codexis Inc offer margin of safetyGlobal Markets & Precise Buy Zone Identification - baoquankhu1.vn
Does Codexis Inc. stock trade at a discount to peersWeekly Investment Summary & Free Growth Oriented Trading Recommendations - mfd.ru
Codexis (CDXS) Achieves ISO 9001:2015 Certification - GuruFocus
Codexis Inc. Achieves ISO 9001:2015 Certification for Quality Management Excellence - Quiver Quantitative
What Codexis’ new ISO 9001 status means for enzyme buyers - Stock Titan
Analysts Expect Breakeven For Codexis, Inc. (NASDAQ:CDXS) Before Long - Yahoo Finance
RSI Check: What makes Codexis Inc stock attractive todayQuarterly Trade Report & Technical Confirmation Trade Alerts - baoquankhu1.vn
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Biofuel Enzymes Market Set to Soar: Innovations Driving - openPR.com
Aberdeen Group plc Expands Stake in Codexis Inc with Significant Share Acquisition - GuruFocus
MACD Signal: Will Codexis Inc benefit from rising consumer demandMarket Performance Recap & Daily Price Action Insights - baoquankhu1.vn
Moving Averages: What are Codexis Incs recent SEC filings showingQuarterly Trade Summary & Growth Oriented Trade Recommendations - baoquankhu1.vn
Aug PreEarnings: What is DYCQRs book value per shareWeekly Investment Report & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Dividend Watch: Is Codexis Inc. stock vulnerable to regulatory risks2025 Sector Review & Daily Momentum Trading Reports - Bộ Nội Vụ
Codexis and Axolabs Partner to Advance Enzymatic RNA Manufacturing - Contract Pharma
How Codexis Inc. stock reacts to Fed rate cutsShare Buyback & Smart Swing Trading Alerts - ulpravda.ru
Codexis CSO Stefan Lutz sells $7949 in shares By Investing.com - Investing.com Nigeria
Codexis CSO Stefan Lutz sells $7949 in shares - Investing.com
Is Codexis Inc. stock safe for conservative investorsJuly 2025 Short Interest & Safe Entry Momentum Tips - Улправда
Codexis (CDXS) Partners with Axolabs for Innovative RNA Manufact - GuruFocus
New partnership tests greener way to mass-produce RNA medicines - Stock Titan
Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics - Yahoo Finance
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Codexis strengthens board with biotech veteran Arthur Levin - MSN
Will Codexis Inc. stock benefit from green energy trendsJuly 2025 Levels & Free Weekly Watchlist of Top Performers - DonanımHaber
Opaleye Management Inc. Reduces Stake in Codexis Inc. - GuruFocus
How Codexis Inc. stock reacts to job market dataPortfolio Profit Report & Expert-Curated Trade Recommendations - Улправда
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):